Questions: Romer Growth Model and R&D-Based Endogenous Growth

5 questions to test your understanding

Score: 0 / 5
Question 1 Multiple Choice

A pharmaceutical firm argues it cannot share its drug formula because sharing would eliminate all incentives to invest in research. Which fundamental tension in the Romer model does this argument reflect?

AThe tradeoff between physical capital investment and consumption in the Solow model
BThe tension between dynamic innovation incentives (requiring monopoly pricing) and the static efficiency loss from underuse of nonrival ideas
CThe problem of diminishing returns to physical capital that makes long-run growth impossible
DThe distinction between exogenous and endogenous technological progress in neoclassical models
Question 2 Multiple Choice

Why does the decentralized market outcome in the Romer model result in too little R&D investment relative to the social optimum?

AFirms prefer physical capital investment because it offers higher private returns than research
BPatents reduce the profitability of R&D by limiting the time period over which innovators can earn returns
CThe private innovator captures only part of the social return from a new idea because each discovery raises the productivity of all future researchers
DResearchers have diminishing marginal utility for discovery, leading them to stop short of the social optimum
Question 3 True / False

In the Romer model, a permanent increase in the fraction of workers employed in R&D leads to a permanently higher long-run economic growth rate.

TTrue
FFalse
Question 4 True / False

In the Solow model, a higher savings rate permanently raises the long-run economic growth rate.

TTrue
FFalse
Question 5 Short Answer

Explain why the nonrivalry of ideas — unlike physical capital — enables sustained long-run growth without diminishing returns.

Think about your answer, then reveal below.